Welcome to the Hawaii Chapter of the American College of Cardiology


2026 Conference
Click here to learn about our annual Chapter meeting April 25, 2026
Click here to download the flyer

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • Noninvasive Predictors of LA Compliance Post TMVT
    In patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...
  • EMPHASIS: Minocycline Initiation Effective, Safe Within 72 Hours of Acute Ischemic Stroke
    Initiation of the multi-target anti-neuroinflammatory drug minocycline within 72 hours of acute ischemic stroke had a significant benefit in functional outcome compared to placebo, with no increased safety risks, according to findings from the EMPHASIS trial published Jan. 30 in The Lancet.
  • Drug-Coated Balloons in Treating Coronary Bifurcation Lesions
    Coronary bifurcation lesions are treated in 15-20% of all percutaneous coronary intervention (PCI) cases and are a challenging scenario. Drug-eluting stents (DES) and better bifurcation PCI techniques improve the treatment of bifurcations beyond bare-metal stents, but stent thrombosis (ST) and in-stent restenosis (ISR) remain threats.
  • ADVANTAGE AF Substudy: PFA vs. Standard RFA For Persistent AFib
    Cavotricuspid isthmus (CTI) ablation with a linear pulsed field ablation (PFA) catheter was associated with safety and efficacy similar to radiofrequency ablation (RFA) and greater efficiency in treating patients with persistent atrial fibrillation (AFib), based on findings from a subanalysis of the ADVANTAGE AF study published in JACC and simultaneously presented at the 31st Annual […]
  • The Case For Earlier LDL Cholesterol Lowering: Supporting Lifelong Healthy Vascular Aging
    Atherosclerosis begins early and progresses silently. Patients requiring secondary prevention have already accumulated decades of low-density lipoprotein cholesterol (LDL-C) exposure resulting in some potentially irreversible arterial aging and injury.